HAL Id: hal-00894020
https://hal.archives-ouvertes.fr/hal-00894020
Submitted on 1 Jan 1994
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of
sci-entific research documents, whether they are
pub-lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Identification of common fragile sites in chromosomes of
2 species of bat (Chiroptera, Mammalia)
E Morielle-Versute, M Varella-Garcia
To cite this version:
Original
article
Identification
of
common
fragile
sites
in chromosomes
of
2
species
of bat
(Chiroptera, Mammalia)
E
Morielle-Versute
M
Varella-Garcia
1
Department of Zoology;
2Department of Biology,
Instituteof Biosciences, UNESP,
PO Box 1,!6, Sdo Jos6 do Rio Preto 15054000,
SP,
Brazil(Received
14 October 1992;accepted
2 December1993)
Summary - In the
karyotypes
of the batspecies
Molossus ater and Mmolossus,
spontaneous andbromodeoxyuridine
(BrdU)-
oraphidicolin
(APC)-sensitive
fragile
siteswere located. Four chromosome
regions
harbored APC-sensitivefragile
sites:lq9
and8q4
in both M ater and Mmolossus, 3q3
inM ater,
andlp7
in M molossus. Thefragile
sites inlq9
and8q4
were also observed without induction in M molossus. BrdU-sensitivefragile
sites were not detected.Despite
observations in several otherspecies,
thefragile
sites detected in Molossus are not coincident with thebreakpoints
involved in the chromosomerearrangements
occurring
in the evolution of 7species
of the Molossidaefamily.
fragile site
/
chromosome/
bat/
bromodeoxyuridine induction/
aphidicolin inductionRésumé - Identification de sites chromosomiques fragiles communs à 2 espèces de chauve-souris.
L’analyse
de lafragilité chromosomique spontanée
ou induite parbromodéoxyuridine
(BrdU)
etaphidicholine
(APC),
réalisée sur le caryotype de2 espèces
de
chauve-souris,
Molossus ater et Mmolossus,
a permisd’identifier 4 sites fragiles
induitspar APC:
1 q9
et8q4
chez M ater et Mmolossus, 3q3
chez M ater et1 p7
chez M molossus. Les sitesfragiles
en1 q9
et 8q4 ont aussi été observés chez M molossus sans induction.Les sites
fragiles repérés
dans cesespèces
ne coincident pas avec les points de cassureimpliqués
dans lesréarrangements chromosomiques
qui ont eu lieu au cours de l’évolutionde 7
espèces
de lafamille
des Molossidae.INTRODUCTION
Fragile
sites arespecific points
on chromosomes which areexpressed
asnon-randomly
distributed gaps and breaks when chromosomes areexposed
tospecific
agents
or culture conditions(Berger
etal,
1985).
The induction offragile
siteexpression
isgenerally
related to imbalance ofdeoxyribonucleotide pools
during
G
1
and Sphases
following thymidylate
stress(Yan
etal,
1988)
or treatment with thethymidine analogue bromodeoxyuridine
(BrdU) (Sutherland
etal,
1985).
Expression
offragile
sites can also be induced athigh frequencies by
inhibitorsof DNA semiconservative and
repair synthesis,
including aphidicolin
(Glover
etal,
1984),
arabinofuranosyl
cytosine,
andarabinofuranosyl
adenosine(Leonard
etal,
1988).
Although
thebiological significance
offragile
sites remainsunclear,
they
have attracted attention since the rarefragile
site inXq27.3
and atype
of X-linked mental retardation in humans were associated(Sutherland
andHecht,
1985).
Furthermore,
several
findings
have correlatedfragile
sites with chromosomalrearrangements
in cancer(Le
Beau,
1986;
DeBraekeleer, 1987;
Mir6 etal,
1987),
infertility
in humans(Schlegelberger
etal,
1989),
breakpoints
involved in chromosomal evolution ofprimates
(Mir6
etal,
1987),
andpreservation
of syntenic
groups in mammals(Djalali
etal, 1987;
Threadgill
andWomack,
1989).
More than 100
fragile
sites have been identified in humanchromosomes,
allclassified
by
their bandlocation,
genesymbol, population
frequencies,
and mode of induction(Mir6
etal, 1987;
Hecht etal,
1990).
BrdU-sensitivefragile
sites havealso been described in Chinese hamsters
(Hsu
andSommers,
1961;
Lin etal,
1984),
cactus mice(Schneider
etal,
1980),
cattle(Di
Berardino etal,
1983),
and reindeer(Gripenberg
etal,
1991).
BrdU-and/or
folate-sensitivefragile
sites wererecently
reported
in the horsekaryotype
(R
o
nne, 1992).
Aphidicolin
(APC)-sensitive
fragile
sites have been detected in the chromosomes of mice
(Djalali
etal, 1987;
Elder andRobinson,
1989;
McAllister andGreenbaum,
1991),
rats(Robinson
andElder,
1987),
dogs
(Wurster-Hill
etal, 1988;
Stone etal, 1991a,
1991b),
pigs
(Riggs
andChrisman,
1991),
and rabbits(Poulsen
andRonne,
1991).
Folate-sensitivefragile
sites were detected in the Persian vole(Djalali
etal,
1985),
the mouse(Sanz
etal,
1986),
cattle(Uchida
etal,
1986),
and in the Indian mole rat(Tewari
etal,
1987).
To determine thepotential
phylogenetic
implications
of chromosomalfragility
in the evolution ofbats,
common BrdU- and APC-sensitivefragile
sites in thekaryotype
of 2species
of thefamily
Molossidae(Chiroptera, Mammalia)
wereexamined.
MATERIALS AND METHODS
Primary
cultures of fibroblasts were derived fromexplants
of ears from a total of 9 animals of thespecies
Molossus ater and 8 from Molossus molossus. The cultures were established and maintained inEagles’
minimum essential medium(MEM)
supplemented
with20%
fetal calf serum,L-glutamine, penicillin
andstreptomycin.
BrdU
(20 gM)
and APC(0.02 gM)
were added to cultures 26 h before harvest. Inwas
performed
with concurrent control cultures. Colchicine(4
x10-
4
M)
was added to the cultures 30 min before harvest. Cells wereexposed
to0.8%
sodium citrate for 30min,
fixed inmethanol/acetic
acid3:1,
dropped
onto wetslides,
and air-dried. Slides werehomogeneously
stained with2%
Giemsa and around 100metaphases
from coded slides of treated and untreated cultures of each animal were scored forbreaks,
gaps, andrearrangements.
After identification of thelesion,
the slides were destained and GTGbanding
(G-band
aftertrypsin
andgiemsa
treatment)
was used toidentify
the exact localization of the aberrations.To determine the presence of a
fragile
site,
2 criteria were considered:(i)
theoccurrence of at least
2%
lesions at agiven
chromosomeregion
in cells submitted to a certain culture condition in at least 2 animals of the samespecies;
and(ii)
thehomozygous
expression
of a lesion. Achi-squared analysis
of the distribution of anomalies wasperformed
to determined whether theirfrequencies
wereequally
distributed in treatments and controls.
RESULTS
The
diploid
number of chromosomes in M ater and M molossus is 2n = 48 and theirkaryotypes
have similarmorphology
and G-bandpattern
(fig 1).
Thefrequencies
of
spontaneous,
BrdU- and APC-induced lesions in bat chromosomes aregiven
in table I. These lesions manifested themselves as eithernonstaining
gaps, chromatid or chromosomebreaks,
or deletions.The number of aberrations in BrdU-treated and untreated
(control)
cultures ofM ater and M molossus was
low,
but BrdU-treated cells weresignificantly
moredamaged
than controls(x
2
=
8.9;
1df;
P <0.05).
Only
3.6%
of the cells in the BrdU-treated cultures and0.6%
of cells in the control cultures showed chromosomelesions in
M ater,
with a total of 20 and 3events,
respectively.
In M molossus3.8%
of the cells in the control culture and4.8%
of BrdU-treated cells showed chromosomeand breaks was variable but
they
occurred in the euchromatic chromosome arms. Chromatid gap was the mostfrequent
event.Four chromosome bands exhibited lesions in at least
2%
of the cells in the BrdU-treated cultures:lq5
andlq9
inM ater; 1q13
and8q4
in M molossus. M molossusbands were considered to harbor
fragile
sites since the aberrations were not observed in thehomozygous
conditions or in more than one animal of the samespecies.
The APC treatment was more effective in the induction of chromosomal aberra-tions than BrdU:
9.2%
of the cellspresented
a total of 50 anomalies inM ater;
11.5%
of the cells exhibited a total of 75 aberrations in M molossus
(table I).
More than one lesion or thehomozygous
expression
of agiven
aberration occurred in a number of cells. In thesetests,
the mostfrequent
type
of aberration was the chromosome gap. Thechi-squared
analysis
detectedsignificantly
moredamaged
chromosomes in the APC-treated than in the control cultures(x
2
=20.0;
1df;
P <0.001).
Fourteen
regions
in the euchromatic arms in which such lesions occurred were identified in at least2%
of the cells:lp7, lq5, lq9, 1q13, 3q3, 4q3-4, 5q8, 7q3-4,
8q4, 8q5-6, lOq3-4, 20q2
andXq4-6
in the APC-treated cultures and1q13-15
in the control cultures(fig 2A).
However, only
4 of these 14regions
fulfilled the criteria to bequalified
asharboring fragile
sites(fig
2B):
lq9
and8q4
in both M ater and Mmolossus, lp7
in MMolossus,
and3q3
in M ater. Thefragile
sites inlq9
and8q4
were also observed without induction in M molossus. Thehighest
expression
rate(8%)
was achievedby 8q4. Furthermore,
an interindividual variation in thefrequencies
ofexpression
of thefragile
sites was observed in all of the 4bands,
as well as aninterspecific
variation observed inlq9
and8q4.
It is
important
toemphasize
that the 5 bands referred to above aspresenting
lesions in the test with BrdU(lp7,
lq5, lq9, 1q13
and8q4)
are included in the14 identified in APC treatment and 3
(1p7,
lq9,
and8q4)
are included in the 4 thatharbored
fragile
sites.DISCUSSION
The mechanisms of
expression
of the BrdU-sensitivefragile
site are nottotally
understood. Thechronology
of the events after exposure to this chemical indicates that it actsduring
the lateS-phase
and affects latereplicating
regions
(Sutherland
etal, 1984,
1985).
An increasedfrequency
of gaps and breaks in the chromosomes of M ater and M molossus was observed when thethymidine
analogue
BrdU wasincorporated. However,
thefrequencies
and conditions in which these alterations wereexpressed
did not fit the criteria forqualification
of the affectedregion
asharboring fragile
sites. Thesefindings
may be related to theperiod
of exposure to BrdU(26
h).
Although
exposure to BrdU for 18-26 h has been used forexperiments
with humanlymphocytes
and several mammalian fibroblasts(Schneider
etal, 1980;
Lin etal, 1984;
Fundia andLarripa,
1989),
thehighest
expression
of common BrdU-sensitivefragile
sites in humanlymphocytes
was achieved after 4-12 h of treatment(Sutherland
etal, 1984,
1985).
Furthermore,
fragile
sites have been identified in bothlymphocyte
and fibroblastcultures,
but the cells in the latter appearrefractory
to their
expression
(Robinson
andElder,
1987).
Hence,
the lowerfrequency
in theexpression
of thefragile
sites in bat fibroblasts may be due to thespecific refractivity
of this celltype
as well as to asusceptibility
oflymphocytes.
(1991)
also confirmed that the aberrations inducedby
this chemical wereprimarily
of the chromatid
type
and included gaps, breaks andinterchanges.
APC,
aditerpenoid mycotoxin
that inhibitsalpha
DNApolymerase
associated with DNAreplication,
induces gaps and breaks at commonfragile
sites in humanchromosomes
(Glover
etal,
1984),
either as chromosome or chromatid aberrations(Murano
etal,
1989).
The mostfrequent
type
of aberration exhibitedby
APC-treated cells in this
study
was the chromosome gap. The results may reflect thenumber of
cycles
a cell hadcompleted
after the introduction of APC intocultures,
and/or
even theefficiency
of therepair
mechanisms.It is
interesting
to note that thefragility
observed in theXq4-6
wasdisplayed by
only
1 animal of thespecies M ater,
and so thisregion
was notqualified
asharboring
a
fragile
site in this work.Corresponding X-fragility
has been observed in severaldistantly
related mammalianspecies
including
humans, horses,
rats,
rabbits, pigs,
study
may thencorrespond
to theXq22
fragility
observed inhumans, horses,
and rats(R
o
nne
etal,
1993).
Since the
species
present
complete homology
in theirkaryotypes,
theinterspe-cific variation was
surprising.
Conservation of5-azacytidine-sensitive fragile
sites was described inprimates
(Schmid
etal,
1985),
as well asfragility
in bands sharedby
horses and humans(Ronne, 1992).
Beyond
theinterspecific
and interindividual variations observed in the number ofregions
harboring fragile
sites,
individual vari-ation in thefrequency
of cellsexpressing
thefragile
sites was also observed amongpositive specimens,
aspreviously reported,
forinstance,
in rabbits(Poulsen
andRonne,
1991)
and humans(Craig-Holmes
etal,
1987).
Variation in the molecular nature of thefragile
sites couldexplain
variation inexpressivity,
asexemplified by
the humanfragile
site inXq27.3.
Ahighly
polymorphic
CGGrepeat
was discovered within the gene FMR-1mapped
in thisregion
and a somatic mosaicism was welldocumented, indicating
mitoticinstability
of alleles(Fu
etal,
1991).
Large
expan-sions of therepeated region
(250-4 000 repeats)
areprobably
moreeasily
detectedby cytogenetic analysis
than smallexpansions
(52-200 repeats).
Despite
the observed association between thefragile
sites and thebreakpoints
involved in chromosomalrearrangements
in several animalspecies
(Djalali
etal,
1985;
Mir6 etal, 1987;
Riggs
andChrisman,
1991),
our results did not show any coincidence between the detected bandsharboring fragile
sites in thespecies
ofMolossus and the
breakpoints
involved in chromosomalrearrangements
occurring
in the evolution of 7
species
of thefamily
Molossidae(Morielle-Versute,
1992).
However a more detailedstudy
is necessary toverify
thecomplete relationship
between these 2phenomena
in bats.ACKNOWLEDGMENTS
We are indebted to FAPESP and FUNDUNESP for
partial
financial support. The authors aregrateful
to VA Taddei forhelping
inidentifying
thespecimens
studied and toJ
Rodrigues
dos Santos and C Antonio N6bile for their excellent technical assistance.REFERENCES
Berger R,
BloomfieldCD,
Sutherland GR(1985)
Report
of the committee on chromosomerearrangements
inneoplasia
and onfragile
site. 8th InternationalWorkshop
on Human GeneMapping. Cytogenet
Cell Genet40,
490-535Craig-Holmes AP, Strong
LC,
GoodacreA,
Pathak S(1987)
Variation in theexpression
ofaphidicolin-induced fragile
sites in humanlymphocyte
cultures. HumGenet
76,
134-137De Braekeleer M
(1987)
Fragile
sites and chromosomal structuralrearrangements
in human leukemia and cancer. Anticancer Res7,
417-422Di Berardino
D,
IannuzziL,
Di Meo GP(1983)
Localization of BrdU-induced break sites in bovine chromosomes.Caryologia
36,
285-292Djalali
M,
Adolph
S,
SteinbachP,
Winking
H,
Hameister H(1987)
Acomparative
mapping
study
offragile
sites in the human and murine genomes. Hum Genet77,
157-162Elder
FFB,
Robinson TJ(1989)
Rodent commonfragile
sites: arethey
conserved? Evidence from mouse and rat. Chromosoma97,
459-464Fu
H-Y,
KuhlDPA,
PizzutiA,
PieretiM,
SutcliffeJS,
RichardsS,
VerkerkAJMH,
HoldenJJA,
Fenwick JrRG,
WarrenST,
OostraBA,
NelsonDL,
Caskey
CT(1991)
Variation of the CGG
repeat
at thefragile
X site results ingenetic
instability:
resolution of the Sherman
paradox.
Cell67,
1047-1058Fundia
A,
Larripa
IB(1989)
Coincidence infragile
siteexpression
withfluoro-deoxyuridine
andbromodeoxyuridine.
Cancer GenetCytogenet
41,
41-48Glover T
W,
Berger
C,
Coyle
J,
Echo B(1984)
DNApolymerase
alpha
inhibitionby
aphidicolin
induces gaps and breaks at commonfragile
sites in human chromosomes. Human Genet67,
136-142Gripenberg
U,
HuwhtanenS,
WissmanM,
Nieminen M(1991)
Afragile
site in the chromosome of the reindeer(Rangifer
tarandus,
L).
Genet SeLEvol 23,
135s-139s HechtF,
RameshKH,
Lochwood DH(1990)
Aguide
tofragile
sites on human chromosomes. Cancer GenetCytogenet
44,
37-45Hsu
TC,
Sommers CE(1961)
Effect of5-bromodeoxyuridine
on mammalian chro-mosomes. Proc Natl Acad ,SciUSA, 47,
396-403Le Beau M M
(1986)
Chromosomalfragile
sites andcancer-specific
rearrangements.
Blood67,
849-858Leonard
JC,
LeonardRC, Thompson
KH(1988)
Arabinofuranosyl
nucleosidesinduce common
fragile
sites. Hum Genet79,
157-162Lin
MS,
Takabayashi
T,
WilsonMG,
Marchese CA(1984)
An in vitro and in vivostudy
of a BrdU-sensitivefragile
site in the Chinese hamster.Cytogenet
Cell Genet38, 211-215
McAllister
BF,
Greenbaum IF(1991)
Aphidicolin-induced
fragile
sites in deer mice(Peromysc!as maniculatus).
Cytogenet
Cell Genet56,
221Mir6
R,
ClementeIC,
FusterC, Egozcue
J(1987)
Fragile
sites,
chromosomeevolution,
and humanneoplasia.
Hum Genet75,
345-349Morielle-Versute E
(1992)
Estudocitogen6tico
emesp6cies
da familia Molossidae(Mammalia, Chiroptera).
DoctoralThesis,
Institute ofBiosciences, UNESP,
Sao Jos6 do RioPreto, SP,
BrazilMorris SM
(1991)
Thegenetic
toxicology
of5-bromodeoxyuridine
in mammalian cells. Mutation Res258,
161-188Murano
I,
KuwanoA, Kajii
T(1989)
Fibroblast-specific
commonfragile
sites inducedby
aphidicolin.
Hum Genet83,
45-48Poulsen
BS,
Ronne M(1991)
High-resolution R-banding
and localizations offragile
sites inOrytolagus
cunicul!s. Genet Sel Evol23,
183s-186sRiggs
PK,
Chrisman CL(1991)
Identification ofaphidicolin-induced
fragile
sites in domesticpig
chromosomes. Genet SelEvol 23,
187s-190sRobinson
TJ,
Elder FFB(1987)
Multiple
commonfragile
sites areexpressed
in the genome of thelaboratory
rat. Chromosoma96,
45-49R
o
Ronne
M, Riggs P,
Gyldenholm A,
Storn 0(1993)
Fragile
sites andfertility
in horses. Proc IOth EurColloq Cytogenet
Domst Anim 18-21August
1992, Utrecht,
University
ofutrecht,
pp 197-200Sanz
M,
JenkinsEC,
BrownWT,
DavissonMT,
KevinM,
RoderickTH,
SilvermanWP, Wisniewsky
HM(1986)
Mouse chromosomefragility.
Am J Med Genet23,
491-509Schlegelberger
B,
Gripp
K,
Grote W(1989)
Commonfragile
sites incouples
withrecurrent
spontaneous
abortions. Am J Med Genet32,
45-51Schmid
M,
OttG,
HaafT,
Scheres JMJC(1985)
Evolutionary
conservation offragile
sites inducedby 5-azacytidine
and5-azadeoxycytidine
in man,gorilla,
andchimpanzee. Hum
Genet71,
342-350Schneider
NR,
Chaganti RSK,
German J(1980)
Analysis
of a BrdU-sensitive site in the cactus mouse(Peromyscus
eremicus):
chromosomalbreakage
and sister-chromatidexchange.
Chromosoma77,
379-389Stone
DM,
Jacky
PB,
HancockDD,
Prieur DJ(1991a)
Chromosomalfragile
siteexpression
indogs.
I. Breedspecific
differences. Am J Med Genet40,
214-222 StoneDM, Jacky PB,
Prieur DJ(1991b)
Chromosomalfragile
siteexpression
indogs.
II.Expression
in boxerdogs
with mast cell tumors. Am J Med Genet40,
223-229Sutherland
GR,
Hecht F(1985)
Fragile
Sites in Human Chromosomes. OxfordUniversity Press,
New YorkSutherland
GR, Jacky PB,
Baker EG(1984)
Hereditablefragile
sites on human chromosomes. XI. Factorsaffecting
expression
offragile
sites at10q25, 16q22
and17pl2.
Am J HumGenet 36,
110-122Sutherland
GR,
ParslowMI,
Baker E(1985)
New Classes of commonfragile
sites inducedby
5’-azacytidine
andbromodeoxyuridine.
Hum Genet69,
233-237 TewariR,
Juyal RC,
ThelmaBK,
DasBC,
Rao SRV(1987)
Folate-sensitive sites on the X-chromosome heterochromatin of the Indian mole rat Nesokia indica.Cytogenet
Cell Genet44,
11-17Threadgill DW,
Womack JE(1989)
Syntenic
assignment
of HSA 9 and HSA 12homologs
in the bovine.Preliminary
evidence for the role offragile
sites in mammalian genome evolution.Cytogenet
Cell Genet51,
1091Uchida
IA,
FreemanVCP,
Basrur PK(1986)
Thefragile
X in cattle. Am J MedGenet
23,
557-562Wurster-Hill
DH,
WardOG,
DavisBH,
ParkJP, Moyzis RK,
Meyne
J(1988)
Fragile
sites,
telomeric DNA sequences, Bchromosomes,
and DNA content in raccoondogs
Nyctereutes procyonoides,
withcomparative
notes onfoxes,
coyote,
wolf,
and raccoon.Cytogenet
Cell Genet49,
278-281Yan